Dahlia Biosciences (Pre-Seed)
Funding Details
Date Award
May 13, 2024
Vertical
Medtech
Company Info
Founders
Un Kwon-Casado, Michael Lin
Market
Human Health
Location
United States
Company Description

Dahlia Biosciences is providing the next generation of multiplexed in situ single-cell RNA analysis tools for research and diagnostic applications. Our vision is to empower scientists to study and isolate cells at high resolution via sensitive, robust, and multiplexed RNA detection in both fixed and live cells.